F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

MORE NEWS

ABOUT US
Logo

Market Fold features extensive coverage of Business and Finance News across the many nations for business leaders who seeks to discover strategy plans of successful businesses.

Contact us: sales[at]marketfold.com


SUBSCRIBE
Copyright © 2015 - 2026 Market Fold. All Rights Reserved.